The Regulatory Intelligence Brief

Supply Chain Resilience in Post-COVID Era: The New Battlefield for Pharmaceutical Excellence Published in The Regulatory Intelligence Brief | 8 min read The COVID-19 pandemic didn’t just disrupt global supply chains—it obliterated the comfortable illusions that pharmaceutical and biotech companies held about their operational invincibility. What emerged from the wreckage...